Medscape

Combo Falls Short for Venous Pressure Reduction in Cirrhosis

The hepatic venous pressure gradient is not reduced, and fluid retention persists across several different doses of zibotentan with dapagliflozin.
News Medical

Study highlights the need for liver cirrhosis patients to be educated on hepatic venous pressure gradient

Just like the hypertension that people develop when their blood pressure increases, the increase of blood pressure in the main vein that supplies blood to the liver, called the portal vein, is also a ...
News Medical on MSN

The mechanisms behind thrombocytopenia in patients with portal hypertension and chronic liver disease

Persistent liver injury halts the regenerative capacity of hepatocytes and activates mechanisms that result in the ...
Medscape

Stiff Spleen Predicts Decompensation in Cirrhotic Patients

Amsterdam, the Netherlands — In a multivariate analysis of compensated cirrhotic patients infected with hepatitis C virus, spleen stiffness and model for end-stage liver disease (MELD) score emerged ...
EurekAlert!

Liver cirrhosis patients need to be educated on hepatic venous pressure gradient, reports a portal hypertension & cirrhosis study

Just like the hypertension that people develop when their blood pressure increases, the increase of blood pressure in the main vein that supplies blood to the liver, called the portal vein, is also a ...